share_log

雲頂新耀-B：董事名單及其角色和職能

EVEREST MED-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

香港交易所 ·  Feb 9 02:49
Summary by Moomoo AI
雲頂新耀有限公司（「本公司」）於2024年2月9日公布了董事會成員名單及其在不同委員會中的角色和職能。董事會成員包括執行董事傅唯先生（主席）、羅永慶先生（首席執行官）和何穎先生（總裁、首席財務官）。非執行董事為曹基哲先生和馮洪剛先生，而獨立非執行董事包括徐海音女士、李軼梵先生和蔣世東先生。董事會下設三個委員會，分別為審核委員會、薪酬委員會和提名委員會，各委員會成員及主席均已明確列出。
雲頂新耀有限公司（「本公司」）於2024年2月9日公布了董事會成員名單及其在不同委員會中的角色和職能。董事會成員包括執行董事傅唯先生（主席）、羅永慶先生（首席執行官）和何穎先生（總裁、首席財務官）。非執行董事為曹基哲先生和馮洪剛先生，而獨立非執行董事包括徐海音女士、李軼梵先生和蔣世東先生。董事會下設三個委員會，分別為審核委員會、薪酬委員會和提名委員會，各委員會成員及主席均已明確列出。
Genting Xinyu Limited (the “Company”) announced on 9 February 2024 the list of Board members and their roles and functions on the various Committees. The members of the Board include Executive Director Mr. Fu Wei (Chairman), Mr. Lo Yongqing (Chief Executive Officer) and Mr. Ho Ying (President, Chief Financial Officer). THE NON-EXECUTIVE DIRECTORS ARE MR. CAO KI-ZHE AND MR. FENG HUNGGANG, WHILE THE INDEPENDENT NON-EXECUTIVE DIRECTORS INCLUDE MS. XU HAI-YING, MR. LI YIFAN AND MR. CHIANG SHIDONG. The Board of Directors sets up three committees, namely the Audit Committee, the Remuneration Committee and the Nomination Committee. The members of each committee and the chairman are clearly listed.
Genting Xinyu Limited (the “Company”) announced on 9 February 2024 the list of Board members and their roles and functions on the various Committees. The members of the Board include Executive Director Mr. Fu Wei (Chairman), Mr. Lo Yongqing (Chief Executive Officer) and Mr. Ho Ying (President, Chief Financial Officer). THE NON-EXECUTIVE DIRECTORS ARE MR. CAO KI-ZHE AND MR. FENG HUNGGANG, WHILE THE INDEPENDENT NON-EXECUTIVE DIRECTORS INCLUDE MS. XU HAI-YING, MR. LI YIFAN AND MR. CHIANG SHIDONG. The Board of Directors sets up three committees, namely the Audit Committee, the Remuneration Committee and the Nomination Committee. The members of each committee and the chairman are clearly listed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more